• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

McKesson

McKesson announces plans to sell UK businesses to Aurelius

November 1, 2021 By Sean Whooley

McKesson (NYSE:MCK) announced today that it entered into an agreement to send its United Kingdom-based business to Aurelius. Aurelius, a pan-European asset management group, will acquire McKesson’s UK businesses, including LloydsPharmacy, LloydsDirect (previously Echo by LloydsPharmacy), AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, LloydsPharmacy Online Doctor, MASTA and John Bell & Croyden, according to a news release. […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Pharmaceutical Tagged With: McKesson

Johnson & Johnson, other companies to pay $26B over opioid crisis

July 22, 2021 By Sean Whooley

California Attorney General Rob Bonta announced a $26 billion settlement with Johnson & Johnson, among other companies, over opioids. The settlement includes Johnson & Johnson, which manufactured and marketed opioids, and pharmaceutical distributors Cardinal, McKesson and AmerisourceBergen. Get the full story at our sister site, Pharmaceutical Processing World.

Filed Under: Business/Financial News, Featured, Legal News, Pain Management Tagged With: Amerisource Bergen, Cardinal, Johnson & Johnson, McKesson

Federal judge dismisses antitrust lawsuit against BD

March 16, 2021 By Chris Newmarker

A federal judge in southern Illinois has dismissed a lawsuit that a small health provider filed against BD (NYSE:BDX) that claimed that the medtech giant engaged in antitrust behavior with distributors Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK). Judge Nancy J. Rosenstengel had previously dismissed the lawsuit by Marion Diagnostic Center and Marion HealthCare, […]

Filed Under: Blog, Business/Financial News, Featured, Legal News Tagged With: antitrust, BD, Cardinal Health, McKesson

How much could Operation Warp Speed change pharma, medtech distribution?

October 7, 2020 By Chris Newmarker

A top U.S. Department of Health and Human Services official used an appearance today at a virtual medtech conference to repeat the U.S. government’s astounding goal for its Operation Warp Speed program: start delivering 300 million doses of a safe, effective COVID-19 vaccine by January 2021. The project could revolutionize not only how pharmaceuticals are […]

Filed Under: Distribution, Featured, Pharmaceutical Tagged With: AdvaMed, Dept. of Health & Human Services (HHS), McKesson, Operation Warp Speed

Feds unveil COVID-19 vaccine distribution plan

September 16, 2020 By Nancy Crotti

The Trump administration today released a plan to distribute an eventual COVID-19 vaccine free of charge, initially to targeted groups and more broadly as supply increases. The government is planning a phased distribution using a contract awarded to McKesson in August. The first recipients could include: Healthcare personnel likely to be exposed to or treat […]

Filed Under: Business/Financial News, Distribution, Drug-Device Combinations, Featured, Lab Instruments & Supplies, Pharmaceutical Tagged With: becton dickinson, coronavirus, COVID-19, McKesson, U.S. Centers for Disease Control and Prevention, U.S. Department of Defense, U.S. Department of Health and Human Services

Feds ink COVID-19 vaccine distro deal with McKesson

August 17, 2020 By Sean Whooley

The U.S. Dept. of Health and Human Services (HHS) and Defense Dept. (DoD) announced a COVID-19 vaccine distribution deal with McKesson. Under Operation Warp Speed, McKesson will become a central distributor of future COVID-19 vaccines and related supplies needed to administer the pandemic vaccinations, according to a news release. Get the full story at our sister […]

Filed Under: Business/Financial News, Distribution, Pharmaceutical Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), McKesson, U.S. Department of Defense

U.S. senators demand investigation of Trump COVID-19 supply chain effort

June 9, 2020 By Nancy Crotti

Three U.S. senators today demanded an investigation into Project Air Bridge, a Trump administration supply chain management project to import personal protective equipment (PPE) and other medical supplies during the COVID-19 pandemic. Dubbing the project “opaque,” U.S. Senators Elizabeth Warren (D-Mass.), Chuck Schumer (D-N.Y.) and Richard Blumenthal (D-Conn.) also released new documents and information from […]

Filed Under: Business/Financial News, Distribution, Featured, Hospital Care, Wall Street Beat Tagged With: Cardinal Health, concordance, COVID-19, Federal Emergency Management Agency (FEMA), Henry Schein Inc., McKesson, Medline Industries Inc., Owens and Minor, supply chain

McKesson appoints chief strategy and business development officer

June 5, 2020 By Danielle Kirsh

McKesson this week said it appointed Tom Rodgers as executive VP and chief strategy and business development officer, effective June 5. Upon the appointment, Rodgers will also become a member of the executive operating team. He succeeds Bansi Nagji who stepped down on March 31. Rodgers will be responsible for the company’s overall strategic plan […]

Filed Under: Business/Financial News Tagged With: McKesson

6 medtech execs join White House economic recovery group

April 15, 2020 By Nancy Crotti

Several medtech executives have been named to the White House task force designated by President Donald Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus  pandemic. The Great American Economic Revival healthcare industry group has 27 members, including: Mike Kauffman, CEO of Cardinal Health (NYSE:CAH). Brian […]

Filed Under: Business/Financial News Tagged With: 3m, Abbott, AdvaMed, coronavirus, COVID-19, Donald Trump, Johnson & Johnson, McKesson, Thermo Fisher Scientific

McKesson names new chief information and technology officer

December 10, 2019 By Danielle Kirsh

McKesson this week announced it appointed Nancy Flores as executive VP, chief information officer and chief technology officer, effective Jan. 13, 2020. Flores will be responsible for the enterprise business technology strategy, technology governance across the corporation, IT security and risk management, infrastructure operations and service delivery. She will replace Kathy McElligott who announced she […]

Filed Under: Business/Financial News, Featured Tagged With: McKesson

ReShape taps Allergan vet Bandy for CEO | Personnel Moves, April 3 2019

April 3, 2019 By Brad Perriello

ReShape Lifesciences (NSDQ:RSLS) said last week that it named Allergan (NYSE: AGN) veteran Barton Bandy to replace Dan Gladney in the corner office, effective April 1. Gladney, who announced his retirement in January, is staying on as chairman. Bandy spent a decade at Inamed until its $3.2 billion purchase by Allergan in 2005. “I am […]

Filed Under: Business/Financial News, Featured Tagged With: Alcon, Bio-Rad, Dept. of Health & Human Services (HHS), ExsoMed, FDA, iCad Inc., McKesson, Novartis, Personnel Moves, polarityte, ReShape Lifesciences, Stryker

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy